Source: http://uscode.house.gov/view.xhtml?req=(title:21%20section:352%20edition:prelim)
Timestamp: 2017-03-24 17:57:18
Document Index: 111722147

Matched Legal Cases: ['§ 352', '§502', '§3', '§2', '§2', '§2', '§1', '§1', '§102', '§105', '§305', '§105', '§6', '§7', '§1205', '§3', '§111', '§3', '§107', '§3', '§114', '§412', '§206', '§301', '§2', '§102', '§2', '§2', '§901', '§306', '§702', '§2', '§103', '§206', '§3037', '§2', '§301', '§2', '§2', '§302', '§112', '§131', '§901', '§3507', '§2', '§906', '§107', '§114', '§9']

TITLE 21 / CHAPTER 9 / SUBCHAPTER V / Part A / § 352
(June 25, 1938, ch. 675, §502, 52 Stat. 1050
; June 23, 1939, ch. 242, §3, 53 Stat. 854
; Dec. 22, 1941, ch. 613, §2, 55 Stat. 851
; July 6, 1945, ch. 281, §2, 59 Stat. 463
; Mar. 10, 1947, ch. 16, §2, 61 Stat. 11
; July 13, 1949, ch. 305, §1, 63 Stat. 409
; Aug. 5, 1953, ch. 334, §1, 67 Stat. 389
; Pub. L. 86–618, title I, §102(b)(2), July 12, 1960, 74 Stat. 398
; Pub. L. 87–781, title I, §§105(c), 112(a), (b), 131(a), title III, §305, Oct. 10, 1962, 76 Stat. 785
, 790, 791, 795; Pub. L. 90–399, §105(a), July 13, 1968, 82 Stat. 352
; Pub. L. 91–601, §6(d), formerly §7(d), Dec. 30, 1970, 84 Stat. 1673
, renumbered Pub. L. 97–35, title XII, §1205(c), Aug. 13, 1981, 95 Stat. 716
; Pub. L. 94–295, §§3(e), 4(b)(2), 5(a), 9(b)(2), May 28, 1976, 90 Stat. 577
, 580, 583; Pub. L. 95–633, title I, §111, Nov. 10, 1978, 92 Stat. 3773
; Pub. L. 102–300, §3(a)(2), June 16, 1992, 106 Stat. 239
; Pub. L. 102–571, title I, §107(9), Oct. 29, 1992, 106 Stat. 4499
; Pub. L. 103–80, §3(m), Aug. 13, 1993, 107 Stat. 777
; Pub. L. 105–115, title I, §§114(a), 125(a)(2)(B), (b)(2)(D), 126(b), title IV, §412(c), Nov. 21, 1997, 111 Stat. 2312
, 2325, 2327, 2375; Pub. L. 107–250, title II, §206, title III, §§301(a), 302(a)(1), Oct. 26, 2002, 116 Stat. 1613
, 1616; Pub. L. 108–214, §2(b)(2)(B), Apr. 1, 2004, 118 Stat. 575
; Pub. L. 108–282, title I, §102(b)(5)(E), Aug. 2, 2004, 118 Stat. 902
; Pub. L. 109–43, §2(c)(1), Aug. 1, 2005, 119 Stat. 441
; Pub. L. 109–462, §2(d), Dec. 22, 2006, 120 Stat. 3472
; Pub. L. 110–85, title IX, §§901(d)(3)(A), (6), 902(a), 906(a), Sept. 27, 2007, 121 Stat. 940
, 942, 943, 949; Pub. L. 112–144, title III, §306, title VII, §§702(a), 714(c), July 9, 2012, 126 Stat. 1024
, 1065, 1074; Pub. L. 112–193, §2(a), Oct. 5, 2012, 126 Stat. 1443
; Pub. L. 113–54, title I, §103(b), title II, §206(b), Nov. 27, 2013, 127 Stat. 597
, 639; Pub. L. 114–255, div. A, title III, §§3037, 3044(b)(2), Dec. 13, 2016, 130 Stat. 1105, 1121.)
Pub. L. 109–462, §2(e)(1), (2), Dec. 22, 2006, 120 Stat. 3472
Pub. L. 107–250, title III, §301(b), Oct. 26, 2002, 116 Stat. 1616
, as amended by Pub. L. 108–214, §2(c)(1), Apr. 1, 2004, 118 Stat. 575
; Pub. L. 109–43, §2(d), Aug. 1, 2005, 119 Stat. 441
, provided that: "Section 502(u) of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 352(u)] (as amended by section 2(c) of the Medical Device User Fee Stabilization Act of 2005 [Pub. L. 109–43])-
Pub. L. 107–250, title III, §302(a)(2), Oct. 26, 2002, 116 Stat. 1616
, provided that: "The amendment made by paragraph (1) [amending this section] takes effect 15 months after the date of the enactment of this Act [Oct. 26, 2002], and only applies to devices introduced or delivered for introduction into interstate commerce after such effective date."
Pub. L. 87–781, title I, §112(c), Oct. 10, 1962, 76 Stat. 791
Pub. L. 87–781, title I, §131(b), Oct. 10, 1962, 76 Stat. 792
, provided that: "No drug which was being commercially distributed prior to the date of enactment of this Act [Oct. 10, 1962] shall be deemed to be misbranded under paragraph (n) of section 502 of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 352(n)], as added by this section, until the earlier of the following dates: (1) the first day of the seventh month following the month in which this Act is enacted; or (2) the effective date of regulations first issued under clause (3) of such paragraph (n) in accordance with the procedure specified in section 701(e) of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 371(e)]."
Pars. (b) and (d) to (h) effective Jan. 1, 1940, and such paragraphs effective July 1, 1940, as provided by regulations for certain lithographed labeling and containers bearing certain labeling, see act June 23, 1939, ch. 242, 53 Stat. 853
, set out as an Effective Date: Postponement in Certain Cases note under section 301 of this title.
Pub. L. 110–85, title IX, §901(d)(3)(B), Sept. 27, 2007, 121 Stat. 940
, provided that: "Not later than 30 months after the date of the enactment of the Food and Drug Administration Amendments Act of 2007 [Sept. 27, 2007], the Secretary of Health and Human Services shall by regulation establish standards for determining whether a major statement relating to side effects and contraindications of a drug, described in section 502(n) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 352(n)) (as amended by subparagraph (A)) is presented in the manner required under such section."
Pub. L. 111–148, title III, §3507, Mar. 23, 2010, 124 Stat. 530
Pub. L. 109–43, §2(c)(2), Aug. 1, 2005, 119 Stat. 441
, provided that: "Not later than 180 days after the date of enactment of this Act [Aug. 1, 2005], the Secretary of Health and Human Services shall issue guidance to identify circumstances in which the name of the manufacturer of the original device, a generally recognized abbreviation of such name, or a unique and generally recognized symbol identifying such manufacturer, is not 'prominent and conspicuous', as used in section 502(u) of Federal Food, Drug, and Cosmetic Act [21 U.S.C. 352(u)] (as amended by paragraph (1))."
Pub. L. 110–85, title IX, §906(b), Sept. 27, 2007, 121 Stat. 950
Pub. L. 108–173, title I, §107(f), Dec. 8, 2003, 117 Stat. 2171
, directed the Secretary of Health and Human Services to undertake a study of how to make prescription pharmaceutical information, including drug labels and usage instructions, accessible to blind and visually-impaired individuals, and to submit a report to Congress not later than 18 months after Dec. 8, 2003.
Pub. L. 105–115, title I, §114(b), Nov. 21, 1997, 111 Stat. 2312
, provided that: "The Comptroller General of the United States shall conduct a study of the implementation of the provisions added by the amendment made by subsection (a) [amending this section]. Not later than 4 years and 6 months after the date of enactment of this Act [Nov. 21, 1997], the Comptroller General of the United States shall prepare and submit to Congress a report containing the findings of the study."
Pub. L. 89–74, §9(a), July 15, 1965, 79 Stat. 234
, provided that: "The Congress finds and declares that there is a substantial traffic in counterfeit drugs simulating the brand or other identifying mark or device of the manufacturer of the genuine article; that such traffic poses a serious hazard to the health of innocent consumers of such drugs because of the lack of proper qualifications, facilities, and manufacturing controls on the part of the counterfeiter, whose operations are clandestine; that, while such drugs are deemed misbranded within the meaning of section 502(i) of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 352(i)], the controls for the suppression of the traffic in such drugs are inadequate because of the difficulty of determining the place of interstate origin of such drugs and, if that place is discovered, the fact that the implements for counterfeiting are not subject to seizure, and that these factors require enactment of additional controls with respect to such drugs without regard to their interstate or intrastate origins."